VP of Medical Services Susan Manley explains what genetic mutations are and how testing can definitively determine whether or not a cancer is hereditary in nature or is sporadically occurring. The results of genetic tests can empower people to take the necessary actions to reduce their risk for cancer.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.